BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
about
Managing breast cancer in younger women: challenges and solutionsSomatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysisTriple negative breast cancer: looking for the missing link between biology and treatmentsp53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptTP53 mutations in human cancers: origins, consequences, and clinical usePrevalence of the TP53 p.R337H mutation in breast cancer patients in BrazilLong-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 statusBreast cancer before age 40 years.Translational advances regarding hereditary breast cancer syndromes.Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion.Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.Prevalence of germline TP53 mutations in HER2+ breast cancer patients.Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryClinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumNew insights into breast cancer genetics and impact on patient managementTumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry.Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H in TP53.High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort.Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.Genomic Disparities in Breast Cancer Among Latinas.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Hereditary breast cancer syndromes and genetic testing.Next generation sequencing is informing phenotype: a TP53 example.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Breast cancer features in women under the age of 40 years.Cancer at ages 15-29 years: the contrasting incidence in India and England.Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.Expression analysis of B-Raf oncogene in V600E-negative benign and malignant tumors of the thyroid gland: correlation with late disease onset.Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark.Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.
P2860
Q26771184-33EAA728-84CD-4054-AB7D-DA011D9DB7F1Q26776018-3DB7FA26-EFC8-4CC4-BF05-93C6EB33B9CFQ26783122-2D947C46-3369-4F1A-A758-66CBA15209B1Q28079390-17687A8C-ACB7-4661-B894-202C4CEBCB68Q33685392-B23FBAF7-2CE7-4141-8443-59FAC8069A2FQ33768942-6D15006E-C108-40B5-8742-99F299229F84Q33783075-3C0AB0F2-A65F-44C0-82AF-F7B6538A3C8DQ33948726-BB7A7B8F-487E-4338-A952-2F64EF19276BQ34263162-06EF59C8-FE69-48A8-902F-B4074CCEF28EQ34294432-2BCC20FD-B297-4FFC-95C6-12D08EFC0700Q34301309-B7AB0C34-DAB0-4C37-AA89-27D840C473ADQ34613122-A1BFE6FC-A098-4C5D-A5C3-A847D59D1766Q34789542-5ED68326-F123-4863-8E0A-AD568103E73EQ35587015-122F08B0-8D3C-4B6F-82AB-E4D14DEBBBD3Q35735103-2FD3DC77-A4AC-44E1-8AEC-A9596EBC7211Q35995839-D5FDF002-54A8-4A1B-B103-A7A4D8E2D457Q36245632-F904991C-9F84-49AA-9834-DCD81811AAB9Q36672536-636062A7-9980-43B8-87AE-345998EDD854Q36883664-006F5972-485B-4EE2-AC1E-1F13945C08BCQ36924465-D4372D66-C3C0-4AB7-8D42-D50C231E55D4Q37006537-D77C53AC-3D80-4F30-A7B4-217832F6859DQ37011934-D65BFC7E-96F8-425E-AA76-C6D0F60D8959Q37033772-E157DD73-DE3D-4BFE-8F7C-3EC444F9CC6CQ37131303-298C7A49-6977-4B65-AA99-D92873A247DDQ37509093-96C9E942-A18F-4F47-85EB-7F82ECB19B91Q38202612-7CFD7C89-E444-4B91-BE5C-54521665E879Q38266306-1917FC47-96D3-416F-B7FB-EEDBFC37FE20Q38783154-7150D61D-EF01-48B6-B365-2348C1B82CC8Q39033804-57C49396-5643-40DD-B45E-C3C4FAC5217FQ39089339-73C207C8-27F5-427B-B49F-8E5F72BD1827Q39954978-AA2BB8BE-AD98-4EAF-B01B-CA15AC403A69Q40238343-442BC385-63C6-41AD-A9DB-A282B3C5CA27Q43993555-4BA1DA3F-B1BA-4CAB-B12F-0631A6CDF6DAQ44211368-C41FF672-B7F6-4C79-868E-6298759B811CQ44358008-8CE432EE-6851-49DC-B99C-E8AC408BA354Q44490673-1F14A66A-7D28-42BE-B792-4BF0D27FA562Q45026999-1BF2B2F5-C198-4E19-B600-445CC70F54A5Q48259632-3CBBCFAB-4C3F-41D1-BBD8-DA243E133A75Q51170853-D6F5A223-8F60-4017-9736-63AB33816127Q53270833-1F4A89DC-C7F9-420E-A5EA-8950E1752458
P2860
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
description
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2006
@uk
name
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@en
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@nl
type
label
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@en
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@nl
prefLabel
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@en
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@nl
P2093
P50
P1476
BRCA1, BRCA2 and TP53 mutation ...... associated risks to relatives
@en
P2093
Andrew Shenton
Anthony Moran
Barbara Bulman
D. Gareth R. Evans
David Ellis
Fiona Lalloo
Jennifer Varley
Lindsay O’Dair
Roger Hartley
Sheila Seal
P304
P356
10.1016/J.EJCA.2005.11.032
P577
2006-05-01T00:00:00Z